Central Motor Mechanisms in AIS Via HD-sEMG, EEG and Neuromuscular Coupling Analysis
Study on the Central Motor Regulation Mechanism in Adolescent Idiopathic Scoliosis (AIS) Patients Based on HD-sEMG, EEG, and Neuromuscular Coupling Analysis
1 other identifier
observational
40
1 country
1
Brief Summary
- 1.Verifying the Motor Control Effects of Spinal Manipulation on AIS Using outpatient and inpatient AIS patients from our department as the study subjects, standardized spinal manipulation treatment is applied. The efficacy is evaluated through a combination of clinical outcome measures, HD-EMG for paraspinal muscle function assessment, and Pro-Kin balance system for trunk stability analysis. This establishes an AIS efficacy platform to further clarify the effectiveness of spinal manipulation in motor control regulation of AIS.
- 2.Investigating the Central Motor Network's Response to Spinal Manipulation in AIS Utilizing high-density sEMG-EEG technology, synchronized brain and muscle electrical signals are collected before and after treatment. By employing a neuromuscular synchronization and coupling analysis approach that integrates linear and nonlinear methods, the characteristic indices of information interaction between the central system and muscles are identified. This further explores the motor control and response characteristics of the muscle-cortex network to spinal manipulation in AIS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 26, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJanuary 3, 2025
December 1, 2024
1.5 years
December 26, 2024
December 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
HD-EMG
Muscle performance was assessed using the SAGA high-density electromyography (EMG) system to evaluate the function and activity of the paraspinal muscles.
Before treatment, and at 4 weeks and 12 weeks after treatment.
Secondary Outcomes (1)
Pro-Kin Balance System
Before treatment, and at 4 weeks and 12 weeks after treatment.
Study Arms (2)
AIS
Healthy Control Group
Interventions
Operation Method: Correct abnormal joint alignment - Manipulatively realign the vertebral segments and pelvis affected by scoliosis. Correct abnormal muscle function - After realigning the vertebral bodies to their normal position, stretch the corresponding tight and shortened muscles while strengthening the muscles that need to be lengthened. Restore joint stability - After adjusting the vertebrae and muscles, instruct the patient to hold the corrected posture for at least 10 seconds, then relax for 10 seconds. Repeat this cycle 3-5 times. Restore sensorimotor control - Provide appropriate movement disturbances to patients maintaining the corrected posture to enhance proprioception and motor memory in the corresponding muscles. The total duration of the manipulation is 20-25 minutes. Treatment is performed twice a week for a total of 12 weeks.
Eligibility Criteria
Adolescent Idiopathic Scoliosis Patients
You may qualify if:
- Patients aged ≥10 years;
- Risser sign grade 0-3;
- Cobb angle between 10° and 40°;
- No prior treatment;
- Female patients within 1 year after menarche or before menstruation;
- The patient's guardian signs the informed consent form for treatment.
You may not qualify if:
- Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic system disorders, or those with mental illnesses;
- Patients with thrombocytopenia, coagulation disorders, or a tendency to bleed;
- Patients who are afraid of the treatment and cannot tolerate it;
- Those who have already received other treatments that may affect the study's outcome measures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the First Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2024
First Posted
January 3, 2025
Study Start
January 1, 2024
Primary Completion
June 30, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
January 3, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share